retatrutide type 2 diabetes phase 2 weight loss Jaime Almandoz, MD MBA FTOS on X: "🚨 is out: 24.2% mean and a quarter lost >30%! Women lost more weight than men. #ADA2023 was like drinking Retatrutide for weight loss: Study

LL-37 is linked with immune activation in some autoimmune skin disease settings, and that is a signal to slow down and get screened first

More typical side effects include nausea, diarrhoea, abdominal pain, reduced appetite and dizziness

Use of glucagon-like peptide 1 agonists for weight loss compared with bupropion-naltrexone was associated with an increased risk for pancreatitis, gastroparesis and bowel obstruction but not biliary disease, researchers reported in JAMA

But panic is not the same thing as risk

Paying modestly more for a product with verified purity and proper documentation proves worthwhile compared to the risks and wasted effort associated with substandard compounds